Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Adding a second method to PROTACs could improve cancer treatment.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Human hair follicles can assess carcinogen metabolism and imidazole compounds might be effective anticarcinogens.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Metformin promotes hair growth by affecting cell growth and protein signaling related to hair growth.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

New progesterone-based compounds can block male hormones.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

New compounds may help treat prostate cancer by reducing cell growth.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.